TAAR1 agonists improve glycemic control, reduce body weight and modulate neurocircuits governing energy balance and feeding

• Автори: Nina Dedic (Автор), Lien Wang (Автор), Eva Hajos-Korcsok (Автор), Jacob Hecksher-Sørensen (Автор), Urmas Roostalu (Автор), Steven P. Vickers (Автор), Serena Wu (Автор), Christoph Anacker (Автор), Colleen Synan (Автор), Philip G. Jones (Автор), Snezana Milanovic (Автор), Seth C. Hopkins (Автор), Linda J. Bristow (Автор), Kenneth S. Koblan (Автор)
• Формат: Книга
• Опубліковано: Elsevier, 2024-02-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

Objective: Metabolic Syndrome, which can be induced or exacerbated by current antipsychotic drugs (APDs), is highly prevalent in schizophrenia patients. Recent preclinical and clinical evidence suggest that agonists at trace amine-associated receptor 1 (TAAR1) have potential as a new treatment optio...